Cardiac regeneration is a promising and evolving field of research focused on restoring damaged or injured heart tissue. Unlike many other tissues in the body, the heart has limited regenerative capacity, and injuries such as myocardial infarction (heart attack) can lead to irreversible damage. The goal of cardiac regeneration is to stimulate the growth of new, functional heart tissue to replace or repair damaged areas. Various approaches are being explored, including the use of stem cells, tissue engineering, and regenerative medicine techniques. Stem cells, with their potential to differentiate into various cell types, have shown promise in promoting the regeneration of cardiac cells. Additionally, researchers are investigating ways to stimulate the heart's endogenous regenerative mechanisms, encouraging the growth of new blood vessels and cardiomyocytes. While still in the early stages of development, the field of cardiac regeneration holds the potential to revolutionize the treatment of heart diseases and improve outcomes for individuals with damaged cardiac tissue.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation